Table 3.
Metabolic parameters for PP study visit days for GDM women with NGT compared to IGT groups
| GDM/NGT | GDM/IGT | |
|---|---|---|
| n | 9 | 5 |
| IGF-I (ng/ml) | 188 ± 17 | 164 ± 26 |
| FFA (μEq/liter) | 601 ± 96 | 569 ± 142 |
| TNF-α (pg/ml) | 6.3 ± 0.6 | 5.1 ± 0.6 |
| MCP-1 (pg/ml) | 254 ± 44 | 207 ± 9 |
| IL-6 (pg/ml) | 2.4 ± 0.4 | 2.5 ± 0.6 |
| IL-8 (pg/ml) | 2.5 ± 0.4 | 2.3 ± 0.5 |
| Leptin (ng/ml) | 1.2 ± 0.2 | 1.4 ± 0.4 |
| Adiponectin (μg/ml) | 1716 ± 275 | 1446 ± 494 |
| Resistin (μg/ml) | 1.6 ± 0.2 | 2.3 ± 0.5 |
| Fasting glucose, mg/dl (mmol/liter) | 82 ± 2 (4.6 ± 0.1) | 91 ± 2 (5.0 ± 0.1)a |
| Glucose (30 min), mg/dl (mmol/liter) | 147 ± 7 (8.2 ± 0.4) | 155 ± 8 (8.6 ± 0.4) |
| Fasting insulin, μU/ml (pmol/liter) | 6 ± 1 (39 ± 7) | 9 ± 2 (54 ± 11) |
| Insulin (30 min), μU/ml (pmol/liter) | 51 ± 11 (303 ± 63) | 42 ± 9 (251 ± 56) |
| Fasting C-peptide (ng/ml) | 1.8 ± 0.2 | 2.5 ± 0.2 |
| C-Peptide (30 min) (ng/ml) | 5.7 ± 0.4 | 7.4 ± 1.3 |
Data are expressed as mean ± sem.
Differences assessed using t tests for independent groups: a P < 0.05.